REN KCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Hedgehog signaling is suggested to be a major oncogenic pathway in medulloblastoma, which arises from aberrant development of cerebellar granule progenitors. Allelic loss of chromosome 17p has also been described as the most frequent genetic defect in this human neoplasia. This observation raises the question of a possible interplay between 17p deletion and the Hedgehog tumorigenic pathway. Here, we identify the human orthologue of mouse REN KCTD11 , previously reported to be expressed in differentiating and low proliferating neuroblasts. Human REN KCTD11 maps to 17p13.2 and displays allelic deletion as well as significantly reduced expression in medulloblastoma. REN KCTD11 inhibits medulloblastoma cell proliferation and colony formation in vitro and suppresses xenograft tumor growth in vivo . REN KCTD11 seems to inhibit medulloblastoma growth by negatively regulating the Hedgehog pathway because it antagonizes the Gli-mediated transactivation of Hedgehog target genes, by affecting Gli1 nuclear transfer, and its growth inhibitory activity is impaired by Gli1 inactivation. Therefore, we identify REN KCTD11 as a suppressor of Hedgehog signaling and suggest that its inactivation might lead to a deregulation of the tumor-promoting Hedgehog pathway in medulloblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a tumor suppressor lost in ~30% of human SHH-MBs”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
In the citing paper
“REN/KCTD11 (here REN), the substrate-receptor subunit of the CRL3REN ubiquitin ligase”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
In the citing paper
“REN maps on chromosome 17p, a region frequently deleted in SHH-MB subgroup, and acts as tumor suppressor which, by promoting degradation of HDAC1, inhibits GLI1 activity and represses SHH-MB growth.”
From SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma (2024) · cites this paper as [8]
Citations
Cites
Prediction of central nervous system embryonal tumour outcome based on gene expression
Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., Kim, J. Y. H., Goumnerova, L. C., Black, P. M., Lau, C., et al. (2002) · Nature · doi:10.1038/415436a · Cited by 2,371
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977
Altered Neural Cell Fates and Medulloblastoma in Mouse patched Mutants
Goodrich, L. V., Milenković, L., Higgins, K. M., & Scott, M. P. (1997) · Science · doi:10.1126/science.277.5329.1109 · Cited by 1,696
Sonic hedgehog regulates the growth and patterning of the cerebellum
Dahmane, N., & Altaba, A. R. I. (1999) · Development · doi:10.1242/dev.126.14.3089 · Cited by 907
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
The POZ domain: a conserved protein-protein interaction motif.
Bardwell, V. J., & Treisman, R. (1994) · Genes & Development · doi:10.1101/gad.8.14.1664 · Cited by 751
Sasaki, H., Nishizaki, Y., Hui, C.-C., Nakafuku, M., & Kondoh, H. (1999) · Development · doi:10.1242/dev.126.17.3915 · Cited by 715
Gli and hedgehog in cancer: tumours, embryos and stem cells
Ruiz i Altaba, A., Sánchez, P., & Dahmane, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc796 · Cited by 708
Wallace, V. A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80195-x · Cited by 648
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis
Dahmane, N., Sánchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H., & Ruiz i Altaba, A. (2001) · Development · doi:10.1242/dev.128.24.5201 · Cited by 479
Research works printed but not linked: 9
- Dahmane, N. & Ruiz-i-Altaba, A. (1999) Development (Cambridge, U.K.) 126, 3089-3100.
- Dahmane, N., Sanchez, P., Gitton, Y., Palma, V., Sun, T., Beyna, M., Weiner, H. & Ruiz i Altaba, A. (2001) Development (Cambridge, U.K.) 128, 5201-5212.
- Giangaspero F. Bigner S. H. Kleihues P. Pitsch T. & Trojanowski J. (2000) in Pathology and Genetics: Tumors of the Nervous System eds. Kleihues P. & Cavenee W. K. (Int. Agency Res. Cancer Lyon France) pp. 129-137.
- Wetmore, C., Eberhart, D. E. & Curran, T. (2000) Cancer Res. 60, 2239-2246.10786690
- Sasaki, H., Nishizaki, Y., Hui, C., Nakafuku, M. & Kondoh, H. (1999) Development (Cambridge, U.K.) 126, 3915-3924.
- Louro, I. D., Bailey, E. C., Li, X., South, L. S., McKie-Bell, P. R., Yoder, B. K., Huang, C. C., Johnson, M. R., Hill, A. E., Johnson, R. L., et al. (2002) Cancer Res. 62, 5867-5873.12384550
- Ruiz i Altaba, A. (1999) Development (Cambridge, U.K.) 126, 3205-3216.
- Lee, Y., Miller, H. L., Jensen, P., Hernan, R., Connelly, M., Wetmore, C., Zindy, F., Roussel, M. F., Curran, T., Gilbertson, R. J. & McKinnon, P. J. (2003) Cancer Res. 63, 5428-5437.14500378
- Wetmore, C., Eberhart, D. E. & Curran, T. (2001) Cancer Res. 61, 513-516.11212243
Cited by
Items 101–184 of 184
Marcotullio, L. D., Ferretti, E., Smaele, E. D., Screpanti, I., & Gulino, A. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:193 · Cited by 25
Self-citationWhi2: a new player in amino acid sensing
Teng, X., & Hardwick, J. M. (2019) · Current Genetics · doi:10.1007/s00294-018-00929-9 · Cited by 25
Sato, T., Torashima, T., Sugihara, K., Hirai, H., Asano, M., & Yoshioka, K. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.08.003 · Cited by 23
Cell death, proliferation and repair in human myocarditis responding to immunosuppressive therapy
Frustaci, A., Chimenti, C., Pieroni, M., Salvatori, L., Morgante, E., Sale, P., Ferretti, E., Petrangeli, E., Gulino, A., & Russo, M. A. (2006) · Modern Pathology · doi:10.1038/modpathol.3800594 · Cited by 23
“Quantification results were showed as MHC α and β mRNA expression normalized with the endogenous control glyceraldehyde-3-phosphate dehydrogenase”
MethodSelf-citationNew developments in medulloblastoma treatment: the potential of a cyclopamine–lovastatin combination
Bar, E. E., & Stearns, D. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.2.185 · Cited by 26
“Ptch suppression of Smo activity is relieved when the Hh ligand binds to Ptch. Smo activation results in a transcriptional response through the Gli family of transcription factors.”
BackgroundInfluentialKCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
Tong, R., Yang, B., Xiao, H., Peng, C., Hu, W., Weng, X., Cheng, S., Du, C., Lv, Z., Ding, C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17145 · Cited by 21
“KCTD11 is identified as a tumor suppressor gene antagonizing Hedgehog signaling in human medulloblastoma (MB) [5, 6].”
BackgroundImplications of hedgehog signaling antagonists for cancer therapy
Xie, J. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00431.x · Cited by 21
DeBerardinis, A. M., Banerjee, U., & Hadden, M. K. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400014t · Cited by 20
Pirone, L., Correale, S., de Paola, I., Zaccaro, L., Simone, G. D., Vitagliano, L., Pedone, E. M., & Gaetano, S. D. (2011) · Journal of Peptide Science · doi:10.1002/psc.1366 · Cited by 19
Sharma, J., Mulherkar, S. A., Chen, U.-I., Xiong, Y., Bajaj, L., Cho, B.-K., Goo, Y. A., Leung, H. E., Tolias, K. F., & Sardiello, M. (2023) · Cell Discovery · doi:10.1038/s41421-023-00533-3 · Cited by 16
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors
Fiore, A. D., Bellardinelli, S., Pirone, L., Russo, R., Angrisani, A., Terriaca, G., Bowen, M., Bordin, F., Besharat, Z. M., Canettieri, G., et al. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100926 · Cited by 16
Adenoviral Vector-Mediated Transfer of the Indian Hedgehog Gene Modulates Lymphomyelopoiesis In Vivo
Kobune, M., Kato, J., Kawano, Y., Sasaki, K., Uchida, H., Takada, K., Takahashi, S., Takimoto, R., & Niitsu, Y. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0741 · Cited by 16
KCTD11Tumor Suppressor Gene Expression Is Reduced in Prostate Adenocarcinoma
Zazzeroni, F., Nicosia, D., Tessitore, A., Gallo, R., Verzella, D., Fischietti, M., Vecchiotti, D., Ventura, L., Capece, D., Gulino, A., et al. (2014) · BioMed Research International · doi:10.1155/2014/380398 · Cited by 16
“The authors declare that there is no conflict of interests regarding the publication of this paper.”
InfluentialSelf-citationDomingo-Gil, E., González, J. M., & Estéban, M. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0037 · Cited by 17
Whi2 signals low leucine availability to halt yeast growth and cell death
Teng, X., Yau, E., Sing, C. N., & Hardwick, J. M. (2018) · FEMS Yeast Research · doi:10.1093/femsyr/foy095 · Cited by 15
Asmar, A. J., Beck, D. B., & Werner, A. A. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112300 · Cited by 15
SALL4 is a CRL3REN/KCTD11 substrate that drives Sonic Hedgehog-dependent medulloblastoma
Lospinoso Severini, L., Loricchio, E., Navacci, S., Basili, I., Alfonsi, R., Bernardi, F., Moretti, M., Conenna, M., Cucinotta, A., Coni, S., et al. (2024) · Cell Death & Differentiation · doi:10.1038/s41418-023-01246-6 · Cited by 13
Self-citationEarly and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma
Asklund, T., Henriksson, R., Axelsson, J., Bergström, Å., Kasper, M., Ögren, M., Toftgård, R., & Riklund, K. (2012) · Acta Oncologica · doi:10.3109/0284186x.2012.724537 · Cited by 13
Expression of Gli1 and PARP1 in medulloblastoma: an immunohistochemical study of 65 cases
Pižem, J., Popović, M., & Cör, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0431-2 · Cited by 13
Oncogenes and Tumour Suppressor Genes
Chattopadhyay, D., & Reeves, H. L. (2007) · Wiley eBooks · doi:10.1002/9780470691861.ch3e · Cited by 12
Strategies for Hedgehog inhibition and its potential role in cancer treatment
Kolterud, Å., & Toftgård, R. (2007) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.03.002 · Cited by 12
Smoothened antagonists: a promising new class of antitumor agents
Gallinari, P., Filocamo, G., JONES, P. G., Pazzaglia, S., & Steinkühler, C. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902852686 · Cited by 12
“More pathway members that act between Smo and Gli in vertebrates include negative components such as Rab23 [87] and Ren [88], as well as proteins exerting a positive effect on Hh signaling, such as Tectonic [89] and MIM/BEG4 [90].”
BackgroundTamber, M. S., Bansal, K. K., Liang, M., Mainprize, T. G., Salhia, B., Northcott, P. A., Taylor, M. D., & Rutka, J. T. (2006) · Child s Nervous System · doi:10.1007/s00381-006-0187-3 · Cited by 12
“The REN tumor suppressor inhibits medulloblastoma growth by impairing both Gli2-dependent gene transcription and SHH-enhanced expression of the target Gli1 mRNA, thereby decreasing the expression of downstream genes [34, 35].”
BackgroundLee, M., Lee, Y., Cho, H.-J., Hong, J.-Y., Kwon, S.-J., Park, C.-G., Lee, H.-Y., Son, J. W., & Kang, J. (2011) · Molecular Biology Reports · doi:10.1007/s11033-010-0672-3 · Cited by 11
Zawlik, I., Zakrzewska, M., Witusik‐Perkowska, M., Golańska, E., Kulczycka-Wojdala, D., Szybka, M., Piaskowski, S., Wozniak, K., Zakrzewski, K. M., Papierz, W., et al. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.04.014 · Cited by 11
Turning off the switch in medulloblastoma: The inhibitory acetylation of an oncogene
Canettieri, G., Marcotullio, L. D., Coni, S., Greco, A., & Gulino, A. (2010) · Cell Cycle · doi:10.4161/cc.9.11.11860 · Cited by 10
“The second, inhibitory mechanism is regulated by the tumor suppressor REN, a protein that was initially identified as a Hedgehog inhibitor, encoded by a gene located in chromosome 17p, deleted in most of medulloblastomas.(9) REN turns off the positive Gli1/HDAC1 feedback loop by downregulating HDAC1 levels.”
BackgroundSelf-citationSMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation
Bordin, F., Terriaca, G., Apostolico, A., Fiore, A. D., Mir, F. T., Bellardinelli, S., Bufalieri, F., Bordone, R., Belardinilli, F., Giannini, G., et al. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02260-4 · Cited by 9
“Dimethyl sulfoxide (DMSO) (Sigma) was added in equivalent amounts as a control.”
Self-citationVriend, J. P., & Marzban, H. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2354-3 · Cited by 9
Xie, L., Ji, X., Tu, Y., Wang, K., Zhu, L., Zeng, X., Wang, X., Zhang, J., & Zhu, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110654 · Cited by 9
Takahashi, C., Suzuki, T., Nishida, E., & Kusakabe, M. (2012) · The International Journal of Developmental Biology · doi:10.1387/ijdb.113333ct · Cited by 8
“For example, it has been shown that KCTD11 is deleted in human medulloblastoma and negatively regulates the Hedgehog signaling pathway by ubiquitin-mediated proteolysis (Di Marcotullio et al., 2004; Canettieri et al., 2010).”
BackgroundMárquez-Cantudo, L., Ramos, A., Coderch, C., & de Pascual‐Teresa, B. (2021) · Molecules · doi:10.3390/molecules26185606 · Cited by 8
“The activation of the Hedgehog pathway promotes the activation of Gli 1 and 2 (glioma-associated proteins) that are transcription factors that will, in their turn, regulate gene expression [48].”
BackgroundAngrisani, A., Fiore, A. D., Trani, C. A. D., Fonte, S., Petroni, M., Severini, L. L., Bordin, F., Belloni, L., Ferretti, E., Canettieri, G., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.638508 · Cited by 8
“Of note, reduced KCASH2 expression (and its related protein KCASH1) has been described in Hh-dependent tumors (De Smaele et al., 2004, 2011; Di Marcotullio et al., 2004), while KCASH2 expression in tumor cells leads to inhibitions of Hh signaling and reduction of tumor cell proliferation (De Smaele…”
BackgroundSelf-citationEpigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery
Strejczek, A., Woszczyk, D., Urbaniak, H., Różańska, M., Robak, M., Matuszewska, Z., & Barciszewska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094925 · Cited by 8
“The synergistic use of the Cul3–REN E3 ubiquitin ligase complex can enhance the suppression of tumor growth [123,124].”
BackgroundZebrafish enhancer trap line showing maternal and neural expression of kctd15a
Gharbi, N., Zhao, X., Ellingsen, S., & Fjose, A. (2012) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2011.01326.x · Cited by 8
“It is known that several KCTD family members are expressed in the nervous system during embryonic development (Resendes et al. 2004; Gamse et al. 2005), and reduced expression of KCTD11 has been associated with pediatric medulloblastoma (Di Marcotullio et al. 2004; Zawlik et al. 2006).”
BackgroundSun, Q., Wei, X., Feng, J., Zhang, R., Shen, Q., Dong, J., Jin, Y., Dong, S., Hou-da, L., & Hu, Y. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00679.x · Cited by 6
Chiou, S., Kao, C.-L., Lin, H.-T., Tseng, W.-S., Liu, R.-S., Chung, C.-F., Ku, H., Lin, C., & Wong, T. (2006) · Child s Nervous System · doi:10.1007/s00381-005-0026-y · Cited by 6
Targeting Stem Cells in Brain Tumors
Lasky, J. L., & Liau, L. M. (2006) · Technology in Cancer Research & Treatment · doi:10.1177/153303460600500312 · Cited by 6
Epigenetic regulation of the Hedgehog-Gli signaling pathway in cancer
Car, D., Sabol, M., Musani, V., Ozretić, P., & Levanat, S. (2010) · Periodicum Biologorum · Cited by 8
Therapeutic targets for medulloblastoma
Wlodarski, P. K., & Jóźwiak, J. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.4.449 · Cited by 5
“The role of Hh signaling in MB is further indicated by the observation, that 39% of sporadic cases of this malignancy are associated with allelic deletion of REN KCTD11 , a gene encoding an antagonist of Gli [27] .”
BackgroundPathology and Classification of Tumors of the Nervous System
Reifenberger, G., Blümcke, I., Pietsch, T., & Paulus, W. (2006) · Springer eBooks · doi:10.1007/3-540-31260-9_1 · Cited by 4
Zhu, L., Xin, Y., He, M., Bian, J., Cheng, X., Li, R., Li, J., Wang, J., Liu, J., & Yang, L. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23685 · Cited by 3
Baehring, J. M. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-5961-z · Cited by 3
AMBRA1 enhances Sonic Hedgehog signaling during cerebellar development and in medulloblastoma
Basili, I., Bufalieri, F., Conenna, M., Navacci, S., Li, Y., Torrejon-Diaz, J., Bernardi, F., Severini, L. L., Marsaud, V., Cancila, G., et al. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.03.008 · Cited by 2
Self-citationInduction of tumor suppressor KCTD11 during periovulatory period in rat ovary
Liu, Y., Li, H., Yu, J., & Li, F. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.05.003 · Cited by 2
Beauchamp, E. M., Serrano, R. M. T., & Platanias, L. C. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-8039-6_5 · Cited by 2
Holmberg, L. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01452.x · Cited by 2
“signal transduction pathway (15) or molecules involved in transcriptional regulation of genes that control the cell cycle such as Wnt ⁄ beta-catenin can be prognostic indicators in medulloblastoma (16).”
BackgroundGarcía, I., Crowther, A., Gama, V., Miller, C. R., Deshmukh, M., & Gershon, T. R. (2015) · Oncogene · doi:10.1038/onc.2015.204 · Cited by 3
“These differentiation-inducing mechanisms include Ren (5), Jsap1 (6), Gpr3 (7), and β-Arrestin (8), all of which converge on the cyclin-dependent kinase inhibitor p27/Kip1, which has been shown to be a potent suppressor of medulloblastoma (9, 10).”
BackgroundBrandal, P., & Heim, S. (2015) · Wiley eBooks · doi:10.1002/9781118795569.ch20 · Cited by 1
Bender, A. M., Rodríguez, F. J., Sarkar, G., & Jenkins, R. B. (2010) · Wiley eBooks · doi:10.1002/9781118010136.ch19 · Cited by 1
Intellectual disability, oncogenes and tumour suppressor genes: the way forward?
Bidart, M., & Coutton, C. (2012) · Journal of Genetics · doi:10.1007/s12041-012-0154-6 · Cited by 1
“Initially, KCTD11 displays allelic deletion as well as significantly reduced expression in medulloblastoma (Di Marcotullio et al. 2004).”
Epigenetics in Stem Cell Biology
Nasr, M., Abed, T., El-Derby, A. M., Ali, M. M., & El‐Badri, N. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-55359-3_7 · Cited by 2
Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors
Sandberg, A. A., & Stone, J. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-510-7_8 · Cited by 2
Control of granule cell precursor proliferation in the developing cerebellum and in medulloblastoma
Yoshioka, K. (2005) · Biomedical Reviews · doi:10.14748/bmr.v16.92 · Cited by 1
“Furthermore, REN antagonizes the Gli-mediated transactivation of Shh target genes (62,64).”
BackgroundHow the Hedgehog Outfoxed the Crab
Altaba, A. R. I. (2007) · Springer eBooks · doi:10.1007/0-387-33777-6_1 · Cited by 1
Utrata heterozygotyczności w nowotworach mózgu pochodzenia zarodkowego u dzieci
Zakrzewska, M., & Liberski, P. P. (2005) · Aktualności Neurologiczne
DESIGN AND SYNTHESIS OF LIGANDS TO MODULATE IMPORTANT CELLULAR PATHWAYS
de Paola, I. (2011) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/8845
A Novel Prognostic Biomarker, Pfetin, in Gastrointestinal Stromal Tumors: Proteomics Study
Kondo, T. (2014) · Springer eBooks · doi:10.1007/978-94-007-7740-8_26-1
Tostar, U. (2010) · Figshare
Molecular Biology and Genetics of Cancer
Gulino, A. (2009) · Springer eBooks · doi:10.1007/978-88-470-1085-7_4
“Restoring high REN expression inhibits medulloblastoma growth by negatively regulating Gli function [ 17 ].”
BackgroundSelf-citationThe Mechanisms of Hedgehog Signal Transduction
Varjosalo, M. T. (2008) · Työväentutkimus Vuosikirja
Hedgehog/GLI signaling in cancer
Aberger, F. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511605536.008
Biological Markers in Pediatric Brain Tumors
de Bont, J. M. (2008)
Zur Rolle des Sonic Hedgehog Aktivierungsweges in der Entwicklung des humanen fetalen Gehirns
Direktor, Ä., & Meyermann, R. (2010)
Medulloblastoma: Part I Epidemiology, Clinical Presentation, and Histologic Characteristics
Coleman, B., McLendon, R. E., Kranz, P. G., & Adamson, D. C. (2012) · Contemporary Neurosurgery · doi:10.1097/01.cne.0000411381.46130.65 · Cited by 2
di L'Aquila, C. D. C. (2016)
de Bustos, C. (2006) · DiVA (Digitala Vetenskapliga Arkivet)
Bal, É. (2016) · theses.fr (ABES) · doi:10.70675/41c3f859z4c4az4003zbe58z0d34e95f66a7
Pak, E. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Structure and Function of Multimeric BTB Proteins and Cullin3 Substrate Adaptors
Ji, X. (2017) · TSpace (University of Toronto)
Majumder, D. (2021) · Current Cancer Therapy Reviews · doi:10.2174/1573394717666210805115050
Lau, J., & Weiss, W. A. (2012) · Neuromethods · doi:10.1007/7657_2012_37
Novel Prognostic Biomarker, Pfetin, in Gastrointestinal Stromal Tumors: Proteomics Study
Kondo, T. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7696-8_26
Baehring, J. M. (2004) · Journal of Neuro-Oncology · doi:10.1007/s11060-004-5394-8
Gadacha, J., Haidar, Z., Roëckel, N., Pauset, A., Castro, C., Provost, C., Hamzé, Z., Humbert, C., Bertaux, K., Lenfant, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.30.661538
Frydrych, I., Řehulka, J., Slavíková, L., Hodoň, J., Pokorný, J., Šidová, V., Medvedíková, M., Slavík, H., Полищук, П. Г., Oždian, T., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110472
“Well-documented examples of mechanisms leading to HH activation are mutation or overexpression of Gli1 (23), Gli2 (24), or SUFU (25), Gli1 chromosomal translocation (26), or Ren deletion (27).”
Structure, Function, and Role of KCTD9 in Human Diseases
刘, 宗. (2025) · Journal of Clinical Personalized Medicine · doi:10.12677/jcpm.2025.44413
The legacy of a humble scientist: Edoardo Alesse, MD, PhD (1958–2025)
Papa, S., & Bubici, C. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00994-6
Haidar, Z. (2019) · theses.fr (ABES) · doi:10.70675/3577ad91z4de1z4642zb506zdfe80f5b9c8a
Wang, F., 陈地龙, Zhang, Y., Shi, Z., Chen, W., Wen, Y., Peng, S., Chen, S., Cao, M., Jiang, S., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102251
BindingDB Entry 50038863: Hedgehog-Gli signaling pathway inhibitors as anticancer agents.
BindingDB (2012) · UC San Diego · doi:10.7270/q22n536m
The GLI transcription factors as a therapeutic target in childhood cancers
Beauchamp, E. M. (2010) · DigitalGeorgetown (Georgetown University Library)
Hedgehog Signaling in Pediatric Brain Tumors
Yoon, J. W., Fangusaro, J., Iannaccone, P. M., & Walterhouse, D. O. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8435-7_8
Metadata
- Authors
- Di Marcotullio, L., Ferretti, E., De Smaele, E., Argenti, B., Mincione, C., Zazzeroni, F., Gallo, R., Masuelli, L., Napolitano, M., Maroder, M., Modesti, A., Giangaspero, F., Screpanti, I., Alesse, E., & Gulino, A.
- Affiliations
- Department of Experimental Medicine and Pathology and Pasteur Institute, Cenci Bolognetti Foundation, University La Sapienza, 324 Viale Regina Elena, 00161 Rome, Italy; Department of Experimental Medicine, University of L'Aquila, 67100 L'Aquila, Italy; Department of Experimental Medicine and Biochemical Sciences, University of Tor Vergata, 00133 Rome, Italy; and Neuromed Institute, 86077 Pozzilli, Italy
- University of Rome Tor Vergata (IT)
- Corresponding author
- Gulino, Alberto
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10833-10838
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC490020
- OpenAlex
- W2164786397
- Semantic Scholar
- 92214e63cd9878d795e5eadb354190c7c7c1b49a
- Cited by
- 179
- References
- 32
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 3 · 2021: 8 · 2020: 5 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 9 · 2012: 15
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- University of Connecticut
- Karolinska Institutet
- Associazione Italiana per la Ricerca sul Cancro
- Rheinische Friedrich-Wilhelms-Universität Bonn
- RIKEN
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- medulloblastoma, Hedgehog signaling, Gli1, chromosome 17p deletion, tumor suppressor, tumor cell proliferation, xenograft tumor growth
- MeSH terms
- Zinc Finger Protein GLI1, Alleles, Animals, Cerebellar Neoplasms, Chromosomes, Human, Pair 17, Humans, Medulloblastoma, Nerve Tissue Proteins, Transcription Factors, Transferases, Transplantation, Heterologous, Potassium Channels, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, Gene Deletion, Cell Cycle Proteins, Mice, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.